# Ascent Industries Co.: overview ACNT · Nasdaq · CIK 95953 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/acnt.md) · [Financials](/companies/acnt/financials.md) · [Filings](/companies/acnt/filings.md) · [Insiders](/companies/acnt/insiders.md) Latest reported revenue: [$25.7m](/filings/0000095953-26-000109.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000095953-26-000109). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [20.9](/filings/0000095953-25-000124.md) | [18.1 d](/filings/0000095953-26-000040.md) | [17.8](/filings/0000095953-26-000076.md) | [18.7](/filings/0000095953-26-000109.md) | [19.7](/filings/0000095953-25-000124.md) | [18.8 d](/filings/0000095953-26-000040.md) | [19.4](/filings/0000095953-26-000076.md) | [25.7](/filings/0000095953-26-000109.md) | | Gross margin | % | [14.4%](/filings/0000095953-25-000124.md) | [19.2% d](/filings/0000095953-26-000040.md) | [17.2%](/filings/0000095953-26-000076.md) | [26.1%](/filings/0000095953-26-000109.md) | [29.7%](/filings/0000095953-25-000124.md) | [18.3% d](/filings/0000095953-26-000040.md) | [14.5%](/filings/0000095953-26-000076.md) | [21.6%](/filings/0000095953-26-000109.md) | | Operating margin | % | [(9.4%)](/filings/0000095953-25-000124.md) | [(13.8%) d](/filings/0000095953-26-000040.md) | [(11.4%)](/filings/0000095953-26-000076.md) | [(14.4%)](/filings/0000095953-26-000109.md) | [(4.1%)](/filings/0000095953-25-000124.md) | [(7.9%) d](/filings/0000095953-26-000040.md) | [(12.2%)](/filings/0000095953-26-000076.md) | [(1.0%)](/filings/0000095953-26-000109.md) | | Net margin | % | [(29.5%)](/filings/0000095953-25-000124.md) | [(5.7%) d](/filings/0000095953-26-000040.md) | [(12.9%)](/filings/0000095953-26-000076.md) | [33.7%](/filings/0000095953-26-000109.md) | [(10.6%)](/filings/0000095953-25-000124.md) | [(5.5%) d](/filings/0000095953-26-000040.md) | [(10.2%)](/filings/0000095953-26-000076.md) | [2.6%](/filings/0000095953-26-000109.md) | | Diluted EPS | $ per share | [(0.61)](/filings/0000095953-25-000124.md) | not reported | [(0.23)](/filings/0000095953-26-000076.md) | [0.65](/filings/0000095953-26-000109.md) | [(0.22)](/filings/0000095953-25-000124.md) | not reported | [(0.21)](/filings/0000095953-26-000076.md) | [0.07](/filings/0000095953-26-000109.md) | | Free cash flow | $m | [3.1 d](/filings/0000095953-25-000124.md) | [8.4 d](/filings/0000095953-26-000040.md) | [(1.0)](/filings/0000095953-26-000076.md) | [(1.5) d](/filings/0000095953-26-000109.md) | [0.7 d](/filings/0000095953-25-000124.md) | [(0.2) d](/filings/0000095953-26-000040.md) | [(5.9)](/filings/0000095953-26-000076.md) | [(3.1) d](/filings/0000095953-26-000109.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [335](/filings/0000095953-23-000008.md) | [262](/filings/0000095953-24-000018.md) | [193](/filings/0000095953-25-000007.md) | [80.8](/filings/0000095953-26-000040.md) | [74.9](/filings/0000095953-26-000040.md) | | Gross margin | % | [18.2%](/filings/0000095953-23-000008.md) | [16.5%](/filings/0000095953-24-000018.md) | [0.8%](/filings/0000095953-25-000007.md) | [13.2%](/filings/0000095953-26-000040.md) | [23.0%](/filings/0000095953-26-000040.md) | | Operating margin | % | [8.2%](/filings/0000095953-23-000008.md) | [5.6%](/filings/0000095953-24-000018.md) | [(19.4%)](/filings/0000095953-25-000007.md) | [(13.4%)](/filings/0000095953-26-000040.md) | [(9.4%)](/filings/0000095953-26-000040.md) | | Net margin | % | [6.0%](/filings/0000095953-23-000008.md) | [8.4%](/filings/0000095953-24-000018.md) | [(13.8%)](/filings/0000095953-25-000007.md) | [(16.8%)](/filings/0000095953-26-000040.md) | [1.2%](/filings/0000095953-26-000040.md) | | Diluted EPS | $ per share | [2.14](/filings/0000095953-23-000008.md) | [2.12](/filings/0000095953-24-000018.md) | [(2.63)](/filings/0000095953-25-000007.md) | [(1.35)](/filings/0000095953-26-000040.md) | [0.09](/filings/0000095953-26-000040.md) | | Free cash flow | $m | [17.6](/filings/0000095953-23-000008.md) | [2.2](/filings/0000095953-24-000018.md) | [20.2](/filings/0000095953-25-000007.md) | [13.6](/filings/0000095953-26-000040.md) | [(2.1)](/filings/0000095953-26-000040.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/acnt/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Mink Brook Asset Management LLC](/funds/2052205.md) | 2026-06-30 | $13.3m | 884,483 | | Reduced −2,286 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $5.2m | 345,062 | | Reduced −425 | | [BARD ASSOCIATES INC](/funds/1105907.md) | 2026-06-30 | $4.8m | 321,984 | | Reduced −3,598 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $4.3m | 283,567 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $4.2m | 279,202 | | Reduced −49,798 | | [Oppenheimer & Close, LLC](/funds/1591377.md) | 2026-06-30 | $3.5m | 233,093 | | Added +73,335 | | [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $3.1m | 203,068 | | Reduced −5,436 | | [HEARTLAND ADVISORS INC](/funds/937394.md) | 2026-06-30 | $3.0m | 200,618 | | New +200,618 | | [De Lisle Partners LLP](/funds/2011184.md) | 2026-06-30 | $3.0m | 197,824 | | Unchanged | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $2.9m | 190,587 | | Added +15,364 | ## Recent filings [All 1,085 filings](/companies/acnt/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-26 | 08:49 ET | [8-K](/filings/0000095953-26-000111.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000095953-26-000111 | | 2026-08-04 | 17:18 ET | [10-Q](/filings/0000095953-26-000109.md) | Quarterly report, period 2026-06-30 | 0000095953-26-000109 | | 2026-08-04 | 16:22 ET | [8-K](/filings/0000095953-26-000107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000095953-26-000107 | | 2026-07-21 | 13:40 ET | [8-K](/filings/0000095953-26-000105.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000095953-26-000105 | | 2026-06-29 | 10:30 ET | [8-K](/filings/0000095953-26-000103.md) | 8.01 Other events | 0000095953-26-000103 | | 2026-06-10 | 12:59 ET | [8-K](/filings/0000095953-26-000084.md) | 5.07 Shareholder vote results | 0000095953-26-000084 | | 2026-05-18 | 11:18 ET | [8-K](/filings/0000095953-26-000078.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000095953-26-000078 | | 2026-05-06 | 17:08 ET | [10-Q](/filings/0000095953-26-000076.md) | Quarterly report, period 2026-03-31 | 0000095953-26-000076 | | 2026-05-06 | 16:18 ET | [8-K](/filings/0000095953-26-000074.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000095953-26-000074 | | 2026-04-30 | 16:14 ET | [DEF 14A](/filings/0000095953-26-000071.md) | Proxy statement, period 2026-06-10 | 0000095953-26-000071 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000095953-26-000040.md), filed Mar 3, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/28761d4c-c184-451f-99c7-0d3acd548c44) ## About the filer - CIK: 95953 - Tickers: ACNT - Exchange: Nasdaq - SIC code: 2800 Chemicals & Allied Products - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 14:28 ET. No prices; not investment advice.